This is a preview of subscription content, log in via an institution to check access.
Reference
Maiorano BA, et al. Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis. Targeted Oncology 18: No. 6, 22 Nov 2023. Available from: URL: http://doi.org/10.1007/s11523-023-01016-x
Rights and permissions
About this article
Cite this article
Haematological toxicity of PARP inhibitors in metastatic prostate cancer. Reactions Weekly 1985, 10 (2023). https://doi.org/10.1007/s40278-023-50780-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-50780-9